Review Article
Zinc Deficiency and Zinc Therapy Efficacy with Reduction of Serum Free Copper in Alzheimer’s Disease
Table 1
Post hoc analysis of cognition change in patients 70 years and older during the six-month controlled trial.
| | Cognition test | Direction of deterioration | Zinc-treated group () | Placebo group () | value |
| | ADAS-Cog | Positive change | −0.76 | +1.27 | 0.037 | | CDR-SOB | Positive change | +0.25 | +0.87 | 0.032 | | MMSE | Negative change | +0.58 | −1.0 | 0.067 |
|
|
